Kephera Diagnostics develops lab-based and point-of-care immunoassays for diagnosing emerging and neglected infectious diseases, including Chagas disease and Lyme disease. Their CLIA-certified laboratory provides accurate testing services to address the urgent need for reliable diagnostics in public health.
Funding
$417.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing emerging and neglected infectious diseases such as Chagas disease, Lyme disease, neurocysticercosis, and liver fluke infection is challenging due to the lack of accurate and readily available diagnostic tools, especially in point-of-care settings. This can lead to delayed or inaccurate diagnoses, hindering effective treatment and disease control efforts.
Solution
Kephera Diagnostics develops and provides both lab-based and point-of-care immunoassays focused on diagnosing emerging and neglected infectious diseases. Their CLIA-certified laboratory offers a range of testing services, including serological tests and tiebreaker assays, to provide accurate and reliable diagnostic results. By focusing on diseases of global significance, Kephera aims to address the unmet needs in infectious disease diagnostics and improve patient outcomes through innovation in immunoassay technology.
Target Audience
The primary customers are healthcare providers, clinical laboratories, and public health organizations seeking accurate and reliable diagnostic testing for emerging and neglected infectious diseases.
Features
- CLIA-certified laboratory providing testing services for Lyme disease, Chagas disease, neurocysticercosis, and liver fluke infection
- Development of both lab-based and point-of-care immunoassays for infectious disease diagnosis
- Serological tests, including ELISA and immunoblot assays, for comprehensive Chagas disease testing
- Focus on diseases impacting millions of people globally, including Zika virus and hookworm infection
- Adherence to strict sample handling and storage protocols to ensure test accuracy